Oncological Prevention and Hyper-early Diagnosis
We offer you the most advanced diagnostic tests to detect cancer in its early stages and design a personalized treatment plan.
What Happens in This Unit?
At HM CIOCC, our Prevention and Hyper-Early Diagnosis
Unit focuses on detecting cancer at its earliest stages—even
before symptoms appear. As a leading reference center in
Europe, we specialize in identifying tumor processes in
asymptomatic individuals starting at age 45.
We believe early detection is essential for effective treatment
and improved survival rates. That’s why we offer a
comprehensive approach that includes personalized risk
assessment, advanced diagnostic techniques, and tailored
care plans designed just for you.
What sets us apart?
Comprehensive Approach
We offer a complete program, from risk assessment to diagnosis and personalized follow-up.
Cutting-edge technology
We use the latest imaging technologies and biomarkers to detect cancer in its earliest stages.
Leaders in research
We research the international validation of new diagnostic tests in liquid biopsy, cross-reactivity studies, and minimal residual disease.
How is it diagnosed?
To offer you the best early detection option, we provide traditional tests, along with state-of-the-art blood and urine analyses, for early and personalized cancer detection. These tests are adapted to your individual needs and risk, allowing us to detect different types of cancer early.
Multi-tumor Tests
Pan-tumor test
A blood test capable of detecting more than 70 types of tumors and their organ of origin, aimed at healthy individuals over 50 years old.
Healthy Woman Test
For women over 50, to detect gynecological tumors (breast, ovary, endometrium, and cervix).
Diabetic Patient Test
Detects a panel of tumors that are more common in diabetic individuals over 50 years old.
Single-tumor Tests
Colorectal cancer
Indicated for women or men over 50 years old. The test is performed with a blood sample.
Breast cancer
Recommended for women from 35 years old. It is performed with a blood test.
Urothelial carcinoma
Bladder and urinary tract in people over 50 with urinary symptoms. The sample is collected via urine.
Pancreatic adenocarcinoma
In first-degree relatives of patients with pancreatic cancer or a genetic predisposition syndrome to cancer. It is performed with a blood test.
Onco-hematological neoplasms
For people over 60 with a family history of leukemia/lymphoma or cytopenias of unknown cause.
Healthy individuals with a suspicious finding
What is the procedure like?
-
Attend the consultation
The expert doctor from the Prevention and Hyper-early Diagnosis Unit will perform a comprehensive assessment and create an individualized plan of screening tests and state-of-the-art molecular tests if they are indicated for your case.
-
Blood and urine sample
If, based on your age, personal history, family history, and previous traditional tests, the expert doctor considers it beneficial, they will request the molecular tests from the HM Hospitales Molecular Medicine Laboratory.
-
Results and personalized plan
In this new consultation, we will explain in detail the results of your molecular tests and the rest of the analyses performed. Based on this information, we will design a completely personalized follow-up or intervention plan together. To maintain your health, the expert doctor in Hyper-early Diagnosis will be your physician for long-term individualized follow-up and control.
Do you need a Second Medical Opinion?
Our oncology experts offer you a comprehensive review of your case, so you can explore all options and feel confident with your treatment plan.